Please assess the completion status of the following clinical trial:

Trial Title: Dose Finding Study With CYT003-QbG10 in Patients With House Dust Mite Allergy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Perennial allergic rhinoconjunctivitis due to clinically relevant allergy towards house dust mite allergens~* Further criteria as defined in the study protocol~Exclusion Criteria:~* Clinically manifested seasonal allergy/-ies which is/are expected to interfere with the patient's study treatment schedule and/or assessments~* Clinically relevant perennial allergy/-ies other than house dust mites allergy~* Contraindication to any study test or procedure~* Further criteria as defined in the study protocol

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): None
- 2 (Type: EXPERIMENTAL): None
- 3 (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).